Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies | Crombie J.L.; Sherman A.C.; CHI-AN CHENG ; Ryan C.E.; Zon R.; el Desjardins M.; Baker P.; McDonough M.; Izaguirre N.; Bausk B.; Krauss J.; Gilboa T.; Senussi Y.; Walt D.R.; Davids M.S.; Brown J.R.; Armand P.; Baden L.R.; Issa N. | Blood Advances | 15 | 15 | |
2022 | Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients | Ogata A.F.; CHI-AN CHENG ; Desjardins M.; Senussi Y.; Sherman A.C.; Powell M.; Novack L.; Von S.; Li X.; Baden L.R.; Walt D.R. | Clinical Infectious Diseases | 86 | 95 | |
2015 | Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III | Singer S.; Ara?jo C.; Arraras J.I.; Baumann I.; Boehm A.; Brokstad Herlofson B.; Castro Silva J.; WEI-CHU CHIE ; Fisher S.; Guntinas-Lichius O.; Hammerlid E.; Irarr?zaval M.E.; Jensen Hjermstad M.; Jensen K.; Kiyota N.; Licitra L.; Nicolatou-Galitis O.; Pinto M.; Santos M.; Schmalz C.; Sherman A.C.; Tomaszewska I.M.; Verdonck De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 57 | 50 | |
2013 | Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy - Update of the EORTC QLQ-H&N35, Phase i | Singer S.; Arraras J.I.; Baumann I.; Boehm A.; WEI-CHU CHIE ; Galalae R.; Langendijk J.A.; Guntinas-Lichius O.; Hammerlid E.; Pinto M.; Nicolatou-Galitis O.; Schmalz C.; Sen M.; Sherman A.C.; Spiegel K.; Verdonck-De Leeuw I.; Yarom N.; Zotti P.; Hofmeister D. | Head and Neck | 24 | 25 | |
2021 | SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity | Sherman A.C.; Desjardins M.; CHI-AN CHENG ; Bausk B.; Izaguirre N.; Zhou G.; Krauss J.; Tolan N.; Walt D.R.; Soiffer R.; Ho V.T.; Issa N.C.; Baden L.R. | Clinical Infectious Disease | 13 | 16 |